Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022
Persistence Market Research
Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022
Persistence Market Research
1
Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022 Persistence Market Research Released New Market Report on “Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022”. Malignant glioma’s are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers. Gliomas account for around 45% of primary brain tumors where children are less likely to develop the risk of gliomas. Gliomas arise from the glial cells or non-neuronal cells hence the name and the cells are supposed to provide support and protection for neurons in the central nervous system and peripheral nervous system. Gliomas are caused due to growing or invading into or creating pressure in nearby the normal brain tissues developing tumors in the brain and spinal cord. According to the grading by WHO (World Health Organization), the grade III tumors are malignant and lead to death within 12 to 24 months. Currently more than 60% of the clinical trials in gene therapy are focused on targeting cancer. Cancer is one of the major and global health issue faced accounting for approximately 8 million deaths globally. Heredity, geography, exposure to electromagnetic radiation and gender are some factors responsible for most of the gliomas. There is no such population or geographies where the risks for malignant glioblastoma is less hence the treatment area is much wide and has large scope for future advancements. The factors which affect this market include the limitations of chemotherapy, approvals rate for various drugs and therapies by regulatory bodies and increasing population. Lifestyle changes is one of the leading factor to acceleration of this market and indulge companies to select promising novel treatments entering the clinical arena. The malignant glioma market can be segmented on the basis of therapy and distribution channel. Based on the therapy the malignant glioma market can be sun-divided into following:
Chemotherapy
Drugs
Alkylating Agents
VEGF/VEGFR inhibitors
Anti angiogenic drugs
Based on the distribution channel the malignant glioma market can be sub-divided into the following:
Hospitals
Cancer Research Organizations
Persistence Market Research
2
Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022
Long term care centers
Diagnostic Centers
Pharmaceutical companies have made significant contributions in the treatment of cancer since the past several decades along with increase in spending over cancer related R&D facilities. The market for cancer is steadily increasing due to advancements in the novel methods of treatment, product innovations and successful clinical trials conducted by pharmaceuticals. There are various activities carried out by the pharmaceuticals globally to overcome the technological challenges through mergers and acquisitions, funding and patents. Companies operating in oncology segments are pre-registering for, Pre-clinical, IND, Phase I, Phase II, Phase III. Interested in report: Please follow the below the links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10076 Depending on geographic region, malignant glioma is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and prevalence cases, followed by Europe where the major pharmaceuticals have their blockbuster drugs and include the major funding associations. It is observed in a survey that 1 in 2 men and 1 in 3 women which accounts for almost 40% of the population in U.S. are at a risk of developing cancer in the coming years. The drug development costs are overriding the costs of investments in R&D and yet there are comparatively less approved drugs which pass the Phase III trials. The developing countries as India and China have a higher scope by collaborating with the large pharmaceutical industry players and develop new drugs. Request TOC (table of content), Figures http://www.persistencemarketresearch.com/toc/10076
and
Tables
of
the
Report:
The companies which are the major players in the malignant glioma market are Sigma-Aldrich Co. LLC., Bristol-Myers Squibb, Genentech Inc. Sun Pharmaceutical Industries Ltd., Cipla Inc., Panacea Biotec., Zydus Cadila and Merck & Co., Inc. The report covers exhaustive analysis on:
Malignant Glioma Market Segments
Malignant Glioma Market Dynamics
Historical Actual Market Size, 2013 - 2015
Persistence Market Research
3
Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022
Malignant Glioma Market Size & Forecast 2016 to 2022
Malignant Glioma Current Trends/Issues/Challenges
Competition & Companies involved
Malignant Glioma Drivers and Restraints
Regional analysis includes
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Follow us on LinkedIn: https://www.linkedin.com/company/persistence-market-research-&consulting Report Highlights:
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
For more Info: http://www.persistencemarketresearch.com/contact-us.asp Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2. The report covers geographic segmentation North America Europe Asia RoW
Persistence Market Research
4
Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022 3. The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4. The report provides company profiles of some of the leading companies operating in the market 5. The report also provides porters five forces analysis of the market. Browse the full “All Upcoming Persistence Market's � report at http://www.persistencemarketresearch.com/forthcoming-reports.asp About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services At Persistence Market Research (PMR), we are in the business of accelerating your business. As a full-service market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability. PMR’s Services Go Beyond Gleaning Data: Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by carefully balancing traditional and modern-day research methodologies. Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. Phone: +1-646-568-7751
Persistence Market Research
5
Malignant Glioma Market: Global Industry Analysis and Forecast 2016 - 2022 USA/Canada Toll Free Number. 1-800-961-0353 E-mail: Sales@persistencemarketresearch.com Web : http://www.persistencemarketresearch.com/
Persistence Market Research
6